Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Daiichi Sankyo
Deloitte
Express Scripts
Citi
Cantor Fitzgerald
Boehringer Ingelheim
Johnson and Johnson
Baxter
Healthtrust

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090033

« Back to Dashboard

NDA 090033 describes RIFABUTIN, which is a drug marketed by Lupin Ltd and is included in one NDA. It is available from three suppliers. Additional details are available on the RIFABUTIN profile page.

The generic ingredient in RIFABUTIN is rifabutin. There are three drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the rifabutin profile page.
Summary for 090033
Tradename:RIFABUTIN
Applicant:Lupin Ltd
Ingredient:rifabutin
Patents:0
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 090033
Ingredient-typeRifamycins
Medical Subject Heading (MeSH) Categories for 090033
Suppliers and Packaging for NDA: 090033
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RIFABUTIN rifabutin CAPSULE;ORAL 090033 ANDA American Health Packaging 60687-198 60687-198-25 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-198-25) > 1 CAPSULE in 1 BLISTER PACK (60687-198-95)
RIFABUTIN rifabutin CAPSULE;ORAL 090033 ANDA Lupin Pharmaceuticals, Inc. 68180-285 68180-285-07 60 CAPSULE in 1 BOTTLE (68180-285-07)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength150MG
Approval Date:Feb 24, 2014TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Fuji
UBS
Johnson and Johnson
Merck
Boehringer Ingelheim
Argus Health
Fish and Richardson
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot